Completed
ETEffect of Ultrasound Guided Embryo Transfer on Pregnancy Rates
What is being tested
GnRh, HMG, HCG, Progesterone
+ GnRh, HMG, HCG, Progesterone
Drug
Who is being recruted
Urogenital Diseases
+ Genital Diseases
+ Infertility
From 20 to 39 Years
+9 Eligibility Criteria
How is the trial designed
Treatment Study
Placebo-Controlled
Interventional
Study Start: September 2009
Summary
Principal SponsorAin Shams Maternity Hospital
Last updated: March 26, 2013
Sourced from a government-validated database.Claim as a partner
Study start date: September 1, 2009
Actual date on which the first participant was enrolled.A total of 90 patients undergoing treatment with ICSI were divided into 2 groups: group 1 (45 patients), had ultrasound guided embryo transfer and group 2 (45 patients), underwent embryo transfer using the clinical touch technique
Principal SponsorAin Shams Maternity Hospital
Last updated: March 26, 2013
Sourced from a government-validated database.Claim as a partner
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.Design Details
90 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Treatment Study
These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Conditions
Criteria
Female
Biological sex of participants that are eligible to enroll.From 20 to 39 Years
Range of ages for which participants are eligible to join.Healthy volunteers allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Urogenital DiseasesGenital DiseasesInfertility
Criteria
4 inclusion criteria required to participate
Age (20-39)
Male factor infertility
Ovarian factor infertility
Unexplained infertility
5 exclusion criteria prevent from participating
Difficult embryo transfer
Endometriosis
FSH > 16 iu/l on cycle day 3
Less than 2 embryos grade A
Show More Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.Treatment Groups
Study Objectives
2 intervention groups are designated in this study
50% chance of being blinded to the placebo group
Treatment Groups
Group I
ExperimentalGnRh, HMG, HCG, Progesterone 45 patients had ultrasound guided embryo transfer during ICSI
Group II
PlaceboGnRh, HMG, HCG, Progesterone 45 patients had embryo transfer using clinical touch technique during ICSI
Study Objectives
Primary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
IVF Unit, Ain Shams Maternity Hospital, Ain Shams University
Cairo, EgyptOpen IVF Unit, Ain Shams Maternity Hospital, Ain Shams University in Google MapsCompletedOne Study Center